Metraipolis › archive › dc_4e9ab3c07f89

Monitoring adherence and patient-reported outcomes during subcutaneous immunotherapy for house dust mites with the AllergyVax app/web platform — Europe PMC PMID:41858440

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41858440
DOI
10.1016/j.jacig.2026.100670
License (as archived)
solo-consultazione
Archived
2026-10-09T06:18:08.032Z
SHA-256 of the archived text
cbb69305f97c95b7a815ce420c00c4b74f4bd29765edf47e2593cfa020f269d7
Stable URL of this page
https://metraipolis.com/documento/dc_4e9ab3c07f89

How to cite

Monitoring adherence and patient-reported outcomes during subcutaneous immunotherapy for house dust mites with the AllergyVax app/web platform — Europe PMC PMID:41858440 — Europe PMC (en), https://europepmc.org/article/MED/41858440 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e9ab3c07f89 (Metraipolis archive dc_4e9ab3c07f89, sha256 cbb69305f97c95b7a815ce420c00c4b74f4bd29765edf47e2593cfa020f269d7)
BibTeX
@misc{dc4e9ab3c07f89,
  title = {Monitoring adherence and patient-reported outcomes during subcutaneous immunotherapy for house dust mites with the AllergyVax app/web platform — Europe PMC PMID:41858440},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41858440},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e9ab3c07f89; sha256 cbb69305f97c95b7a815ce420c00c4b74f4bd29765edf47e2593cfa020f269d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41858440. Agents can read the archived copy with the MCP tool read_document.